Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

3.1K
Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
3.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

35.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bioprocess Design and Optimization of Extracellular Vesicles Derived from Mesenchymal Stromal Cells.

ACS nano·2026
Same author

A Bayesian deep segmentation framework for glioblastoma tumor segmentation using follow-up MRIs.

Frontiers in neuroimaging·2025
Same author

Encapsulation of Microalgae <i>Tisochrysis lutea</i> Extract in Nanostructured Lipid Carriers (NLCs) and Evaluation of Their Sunscreen, Wound Healing, and Skin Hydration Properties.

Marine drugs·2024
Same author

The Role of Soluble CD163 (sCD163) in Human Physiology and Pathophysiology.

Cells·2024
Same author

Comprehensive analysis of lipid nanoparticle formulation and preparation for RNA delivery.

International journal of pharmaceutics: X·2024
Same author

Cost-effectiveness Analysis of Colorectal Cancer Screening Strategies Using Active Learning and Monte Carlo Simulation.

Medical decision making : an international journal of the Society for Medical Decision Making·2024

Related Experiment Video

Updated: Jun 27, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.6K

Stable Dual miR-143 and miR-506 Upregulation Inhibits Proliferation and Cell Cycle Progression.

Archana Shrestha1, Behnaz Lahooti2, A K M Nawshad Hossian1

  • 1School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, Monroe, LA 71201, USA.

International Journal of Molecular Sciences
|April 27, 2024
PubMed
Summary

Combining microRNAs (miRs) shows promise for lung cancer therapy. Dual upregulation of miR-143 and miR-506 induced cell cycle arrest and slowed proliferation, outperforming individual miR treatments.

Keywords:
dual miR therapylentiviral transductionlung cancermiR-143miR-506microRNAquantitative phase imaging

More Related Videos

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

27.3K
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.3K

Related Experiment Videos

Last Updated: Jun 27, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.6K
Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

27.3K
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.3K

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Lung cancer pathogenesis involves dysregulated cell cycle, apoptosis, and proliferation.
  • Individual microRNA (miR) targeting is a potential therapeutic strategy.
  • Combining miRs may enhance efficacy and overcome limitations of single-miR approaches.

Purpose of the Study:

  • To evaluate the effects of stable miR-143 and miR-506 deregulation in A549 lung cancer cells.
  • To compare the efficacy of combined miR upregulation/downregulation versus individual miR treatments.
  • To assess the impact of miR deregulation on cell cycle, proliferation, morphology, and motility.

Main Methods:

  • Lentiviral transduction was used for stable upregulation or downregulation of miR-143 and miR-506.
  • Quantitative PCR (qPCR) was employed to analyze miR deregulation.
  • Effects on cell cycle, proliferation, morphology, and motility were determined.

Main Results:

  • Combined miR-143/506 upregulation led to G2 cell cycle arrest and increased cell doubling time.
  • Dual downregulation of miR-143/506 increased cellular motility.
  • Individual miR deregulations showed less pronounced or inconsistent effects compared to combined treatments.

Conclusions:

  • Combinatorial miR therapy, particularly dual upregulation, offers advantages over individual miR treatments for lung cancer.
  • Stable, combined miR deregulation demonstrates sustained therapeutic potential.
  • This study highlights the benefits of miR combinations in overcoming limitations of single-miR strategies.